Ultrasound and HIDA Scan for Cholecystitis

Right-upper-quadrant ultrasound is the first imaging study for suspected acute cholecystitis, and it has been the standard for decades. The American College of Radiology Appropriateness Criteria classifies it as "usually appropriate" — the highest category — for right-upper-quadrant pain with suspicion of biliary disease. The Tokyo Guidelines TG18 incorporate ultrasound findings into the imaging-criteria category that contributes to a definite diagnosis. Published sensitivity estimates for ultrasound in acute cholecystitis range from approximately 80 to 88 percent, with specificity around 80 percent, depending on the cohort and the reference standard.

Ultrasound evaluates for several hallmark findings. Gallstones are present in roughly 90 to 95 percent of acute cholecystitis cases — acalculous cholecystitis is the exception and requires a separate diagnostic pathway. Gallbladder wall thickening greater than three millimeters in a patient who is not fluid-overloaded is a characteristic inflammatory sign. Pericholecystic fluid — a thin rim of free fluid around the gallbladder — is a further supportive finding, as is a sonographic Murphy sign, in which maximal tenderness under the ultrasound probe corresponds to the location of the gallbladder. Gallbladder distension, reflecting the obstruction at the cystic duct, is commonly seen.

The advantages of ultrasound are practical: it is fast, bedside-capable in emergency departments with point-of-care capability, inexpensive relative to cross-sectional imaging, radiation-free, and widely available around the clock in American hospitals. Its limitations are operator-dependence and a modest sensitivity for very early cholecystitis and for acalculous disease — but in the vast majority of pattern cases, the findings are visible to any credentialed sonographer.

The hepatobiliary iminodiacetic acid (HIDA) scan is a nuclear medicine study that evaluates the patency of the cystic duct. A radioactive tracer is injected intravenously, taken up by hepatocytes, and secreted into the bile. The scanner follows the tracer as it moves through the liver, into the bile ducts, into the gallbladder, and into the duodenum. Under normal conditions, the gallbladder fills with tracer within sixty minutes. When the cystic duct is obstructed — the mechanism underlying acute calculous cholecystitis — the gallbladder does not fill, and the non-visualization at sixty minutes is the diagnostic finding.

The published sensitivity for HIDA in acute cholecystitis is approximately 96 percent, with specificity around 90 percent, which makes it the most specific test in the cholecystitis workup. The trade-off is time — the study requires one to four hours to complete, it requires availability of a nuclear medicine technologist and equipment, and it is not always available on nights and weekends at smaller facilities. Morphine augmentation, in which a small dose of morphine is administered to contract the sphincter of Oddi and encourage tracer entry into the gallbladder, is used to improve specificity when the initial scan is equivocal.

HIDA is typically indicated when ultrasound is equivocal or non-diagnostic in a patient with a high pre-test probability, when the clinical picture strongly suggests cholecystitis but ultrasound is negative, and in cases where acalculous cholecystitis is suspected. In the emergency-department workflow, the decision to proceed from ultrasound to HIDA is usually made when the first study does not resolve the clinical question and the patient cannot be safely discharged.

Computed tomography of the abdomen and pelvis is one of the most commonly ordered studies in American emergency departments, typically for undifferentiated abdominal pain. It is widely available, fast, and provides comprehensive anatomic information across multiple organ systems. It is not, however, the first-line study for suspected acute cholecystitis specifically. The American College of Radiology classifies ultrasound as the preferred initial imaging for right-upper-quadrant pain with suspicion of biliary disease, and CT as a complementary study for patients in whom the diagnosis is unclear after ultrasound or for patients in whom alternative diagnoses are also being considered.

When CT is the study that ends up being performed — often because the ordering physician had a broader differential that included appendicitis, diverticulitis, or other intra-abdominal pathology — it can still identify acute cholecystitis. The findings include gallbladder wall thickening, pericholecystic fluid, pericholecystic fat stranding, gallbladder distension, gallstones when sufficiently calcified, and in more advanced cases, abnormal wall enhancement suggesting ischemia. When the gallbladder has progressed to the gangrenous stage, the wall enhancement becomes patchy or absent in the necrotic segments, and gas within the wall or lumen may be visible in emphysematous cases. Free intraperitoneal fluid and pericholecystic abscess are signs of perforation.

The malpractice question with CT is not whether it was performed. It is frequently performed in undifferentiated-abdominal-pain workups. The question is whether the findings were identified, whether a right-upper-quadrant ultrasound was added when biliary disease emerged as the leading diagnosis, and whether the radiology read matched the eventual operative findings. A CT report that described a thickened, inflamed gallbladder that the ER physician discharged as "non-specific" is a different case than a CT that was never ordered.

Magnetic resonance cholangiopancreatography (MRCP) is a non-contrast MRI technique that produces highly detailed images of the biliary tree and pancreatic duct. It is not typically part of the routine acute-cholecystitis workup, but it plays a specific role when the common bile duct must be evaluated. The primary indication is suspected choledocholithiasis — a gallstone that has migrated out of the gallbladder into the common bile duct, causing obstruction, jaundice, and the risk of cholangitis or gallstone pancreatitis.

The Tokyo Guidelines for acute cholangitis (TG18) reference MRCP as the non-invasive imaging standard for evaluating the biliary tree when ductal stones are suspected, and the American College of Radiology Appropriateness Criteria similarly list it as usually appropriate for that indication. Sensitivity for choledocholithiasis in the published literature is in the range of 85 to 95 percent, depending on stone size. Endoscopic retrograde cholangiopancreatography (ERCP) remains the therapeutic modality when stones are confirmed and intervention is needed, but its use as a purely diagnostic study has declined as MRCP has matured.

In the malpractice context, MRCP enters the picture when a patient with jaundice, elevated liver enzymes, or suspected cholangitis was worked up without it and subsequently deteriorated. The standard of care does not require MRCP in every case of right-upper-quadrant pain — that would be a misreading of the guidelines — but when the clinical picture suggests ductal involvement, omitting the study that defines the ductal anatomy becomes a reviewable decision.

The American College of Radiology (ACR) Appropriateness Criteria are the reference framework that radiologists, hospital quality committees, and expert reviewers apply when evaluating whether the imaging approach to a clinical presentation met the standard of care. They are evidence-based guidelines, updated regularly, and they cover the major clinical scenarios in emergency radiology, including right-upper-quadrant pain with suspected biliary disease.

For the scenario "right upper quadrant pain, suspected biliary disease," the ACR criteria rate several studies. Ultrasound abdomen is rated as "usually appropriate" — the highest category, indicating that the study is generally indicated in the specified clinical scenario. Cholescintigraphy (HIDA scan) is rated as "may be appropriate" or "usually appropriate" depending on the specific sub-scenario, reflecting its role as a second-line confirmatory study. CT abdomen with intravenous contrast is rated as "may be appropriate" in some sub-scenarios, reflecting its complementary rather than primary role. MRI abdomen and MRCP are rated as "may be appropriate" in scenarios where ductal pathology is suspected.

In a malpractice analysis, the ACR criteria serve as a neutral anchor for the standard-of-care discussion. An expert can testify that the ACR-rated first-line study for the presentation was not ordered, that the chart documents a presentation consistent with that scenario, and that no alternative rationale for skipping the study is recorded. When the plaintiff's expert and the defense expert disagree, they are often arguing about how the specific facts map onto the ACR framework rather than about whether the framework itself is authoritative.

There are two distinct failure modes in the imaging cascade, and they are often conflated. The first is the skipped study — the chart shows a clinical presentation that warranted imaging, and no imaging was ordered. The second is the misread study — imaging was obtained, and the findings were either missed by the radiologist, misinterpreted by the ordering physician, or not communicated clearly between the two.

The skipped-study case is usually the emergency physician's case. The chart shows right-upper-quadrant pain, a likely inflammatory laboratory pattern, and no ultrasound. The discharge diagnosis is GI in nature. The patient returns 48 to 72 hours later with findings that an ultrasound would have identified at first presentation. The standard-of-care analysis focuses on the decision not to image.

The misread-study case is often the radiologist's case, or a shared-liability case between the radiologist and the emergency physician. The chart shows that ultrasound or CT was ordered, and the report describes findings that were later shown to be consistent with acute cholecystitis — but the report did not identify cholecystitis as the likely diagnosis, and the ordering physician took the report at face value. When the same images are reviewed by a second radiologist after the patient progresses, the findings become obvious in retrospect. These cases involve discovery of the actual images, not just the reports, and side-by-side review by a board-certified radiologist expert.

In both failure modes, the downstream harm is measured by how far the progression went before the correct diagnosis was made. The mechanism of the miss is different, but the damages follow the same trajectory.

The imaging cascade for suspected cholecystitis is designed to be completed within the timeframe of an emergency-department visit, not over days. Right-upper-quadrant ultrasound is typically obtained within one to two hours of the order in a fully-staffed facility, though the actual turnaround varies with the time of day, the availability of the sonographer, and the radiologist read time. When ultrasound is equivocal and HIDA is indicated, the HIDA study itself takes one to four hours to complete once the tracer is administered. CT, when ordered, typically delivers a report within thirty to ninety minutes in most departments.

Delays at the imaging stage affect outcomes. A patient admitted to the emergency department at 8 PM with right-upper-quadrant pain who is not scanned until the following morning has lost hours of the progression window. A patient in a small hospital where nuclear medicine is only available during business hours may face an overnight delay for HIDA. These are real-world constraints, and the standard of care accounts for them — but the chart should document the constraint and the alternative plan. A chart that simply shows a delay with no explanation looks different, in review, than a chart that shows the physician escalating the case, consulting with surgery, and admitting the patient for early-morning imaging.

The relationship between imaging timing and the progression timeline — roughly one to three days from onset of obstruction to gangrene, another day or two to perforation — is the clinical reason the cascade is designed to finish within hours, not days. Every hour of delay eats into that window.

The imaging-driven malpractice analysis turns on a handful of specific questions. Was the first-line study ordered? If yes, was it read correctly? If no, was a documented rationale for the omission in the chart? If the first-line study was equivocal, was the confirmatory study ordered? If yes, was it read correctly? If no, was the patient admitted for observation rather than discharged? When these questions are answered by reference to the actual record, the standard-of-care picture tends to resolve clearly.

Expert review is the mechanism by which the picture is documented for the case. A board-certified radiologist expert reviews the images directly — not just the reports — and opines on what should have been identified and reported. A board-certified emergency physician expert reviews the full ER record and opines on whether the imaging strategy met the standard. When the two align and the downstream progression is well-documented, the case moves toward settlement. When they disagree on the specific facts, the case goes through discovery and often proceeds to deposition before resolving.

For a deeper look at the progression pattern that imaging omissions enable, see our explainer on gangrenous cholecystitis and the missed-diagnosis pattern. For the companion piece on how the emergency department anchors on GI diagnoses and skips the imaging cascade, see ER misdiagnosis of gallbladder pain. For the underlying mini-hub, see delayed diagnosis of cholecystitis.